Thinking of joining a study?

Register your interest

NCT04904146 | RECRUITING | Mycosis Fungoides


Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Sponsor:

Lund University Hospital

Brief Summary:

A translational study for identification of prognostic and treatment-predictive biomarkers in Mycosis fungoides and Sézary syndrome.

Condition or disease

Mycosis Fungoides

Cesarean Syndrome

Intervention/treatment

Blood tests and testing of analysis of the lymphoma microenvironment in skin, skin barrier and skin microbiology profile.

Study Type : OBSERVATIONAL
Estimated Enrollment : 120 participants
Official Title : Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
Actual Study Start Date : 2021-04-02
Estimated Primary Completion Date : 2027-04
Estimated Study Completion Date : 2027-04

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 100 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • * Age 18-100 years
  • * Histologically confirmed (according to the World Health Organization (WHO)/EORTC classification) MF/SS stages I-IV
  • * WHO performance status 0 -3
  • * Absence of psychiatric illness or condition which could interfere with the subjects' ability to understand the requirements of the study.
  • * Written informed consent according to International Conference on Harmonization (ICH)/(Good Clinical Practice (GCP), and Swedish regulations
  • * No minimum or maximum required routine laboratory data
Exclusion Criteria
  • Not applicable. No exclusion criteria are specified.

Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.

Location Details

NCT04904146


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

Sweden,

Lund University Hospital

Lund, Sweden, SE-221 85

Loading...